Lista de Contribuciones

52 / 52
Sr. Bernardo Valdivieso Andres (Secretario autonómico de Planificación, Información y Transformación Digital), Cesar Domingo-Pardo (IFIC (CSIC-University of Valencia)), Juan Antonio Fuster Verdu (IFIC (Instituto de Fisica Corpuscular))
21/2/24 11:00
José Perez Calatayud (Hospital La Fe, Valencia)
21/2/24 11:30
Juan Antonio Vera (Quironsalud)
21/2/24 11:55
Dr. Severine Rossomme (IBA)
22/2/24 11:30
Daniel Esperante Pereira (IFIC), Daniel Esperante Pereira (IFIC - U. de Valencia / CSIC)
22/2/24 16:40
Marta Ibañez (CIEMAT)
23/2/24 9:00
Sr. Nathan AZEMAR (LPC Caen), Cathy Fontbonne ( Université de Caen Normandie, ENSICAEN, CNRS/IN2P3, LPC Caen UMR6534, F-14000 Caen, France), Jean Claude Quintyn ( Department of ophthalmology, University hospital, Caen, France), Dorothee Lebertz (Université de Caen Normandie, ENSICAEN, CNRS/IN2P3, LPC Caen UMR6534, F-14000 Caen, France & Department of radiation therapy, Centre François Baclesse, Caen, France), Jean Marc Fontbonne ( Université de Caen Normandie, ENSICAEN, CNRS/IN2P3, LPC Caen UMR6534, F-14000 Caen, France), Juliette Thariat ( Université de Caen Normandie, ENSICAEN, CNRS/IN2P3, LPC Caen UMR6534, F-14000 Caen, France & Department of radiation therapy, Centre François Baclesse, Caen, France)
23/2/24 9:40
Oral contribution (15'+5')

Tumors located near the optic pathways pose a particular challenge due to the risk of optical toxicities. For this reason, they are often treated with proton therapy. Such patients with paraoptic tumors represented more than half the whole patient population, suggesting referral biases to proton therapy toward difficult to treat tumors.
The PIOTox study aims to conduct a voxel-scale analysis...

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now

×